Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism

Gostelow, R, Scudder, C; Keyte, S; Forcada, Y; Fowkes, R C; Schmid, H A; Church, D B; Niessen, S J M

doi:10.1111/jvim.14662

Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism

Gostelow, R, Scudder, C; Keyte, S; Forcada, Y; Fowkes, R C; Schmid, H A; Church, D B; Niessen, S J M

Authors

R, Scudder, C Gostelow

S Keyte

Y Forcada

R C Fowkes

H A Schmid

D B Church

S J M Niessen

Citation

Gostelow, R. S. C., Keyte, S., Forcada, Y., Fowkes, R. C., Schmid, H. A., Church, D. B., & Niessen, S. J. M. (in press). Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism. Journal of Veterinary Internal Medicine, 31(2), 355-364. https://doi.org/10.1111/jvim.14662

Journal Article Type	Article
Acceptance Date	Jan 3, 2017
Deposit Date	Feb 3, 2017
Publicly Available Date	Feb 3, 2017
Journal	Journal of Veterinary Internal Medicine
Print ISSN	0891-6640
Electronic ISSN	1939-1676
Publisher	Wiley Open Access
Peer Reviewed	Peer Reviewed
Volume	31
Issue	2
Pages	355-364
DOI	https://doi.org/10.1111/jvim.14662
Public URL	https://rvc-repository.worktribe.com/output/1394016